334
Participants
Start Date
November 15, 2012
Primary Completion Date
February 28, 2019
Study Completion Date
February 28, 2019
Cisplatin
Cetuximab
St Luke's Hospital, Dublin
Beaumont Hospital, Dublin
VU University Medical Center, Amsterdam
Aberdeen Royal Infirmary, Aberdeen
Bradford Royal Infirmary, Bradford
Colchester General Hospital, Colchester
Castle Hill Hospital, Cottingham
Royal Derby Hospital, Derby
New Cross Hospital, New Cross
Northampton General Hospital, Northampton
Norfolk & Norwich University Hospital, Norwich
Glan Clwyd Hospital, Rhyl
Royal Shrewsbury Hospital, Shrewsbury
Royal Marsden Hospital, Sutton
Musgrove Park Hospital, Taunton
Royal United Hospital, Bath
Clatterbridge Cancer Centre, Bebington
Bristol Haematology & Oncology Centre, Bristol
Velindre Hospital, Cardiff
Cheltenham General Hospital, Cheltenham
University Hospitals Coventry & Warwickshire, Coventry
Queen Elizabeth Hospital Birmingham, Edgbaston
Western General Hospital, Edinburgh
Royal Devon & Exeter Hospital, Exeter
Royal Surrey County Hospital, Guildford
St James's Institute of Oncology, Leeds
Leicester Royal Infirmary, Leicester
University College Hospital, London
Royal Marsden Hospital, London
James Cook University Hospital, Middlesbrough
Nottingham University Hopsital, Nottingham
Weston Park Hospital, Sheffield
Singleton Hospital, Swansea
Collaborators (1)
Cancer Research UK
OTHER
University of Birmingham
OTHER
University of Oxford
OTHER
University of Warwick
OTHER